IGLVI-68

Across TCGA pan-cancer cohorts, IGLVI-68 RNA is linked to patient survival in 7 of 34 cancer types, making it the most broadly survival-associated IGLVI-68 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher IGLVI-68 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated IGLVI-68 expression acts as an unfavorable survival marker, although some lineages such as BLCA show a favorable association.

BLCA, STAD, and PAAD are the cancer types where IGLVI-68 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	1.000	0.428	.022	39	view →
STAD	OS	Tertile	All	0.513	0.701	.006	36	view →
PAAD	DFS	Tertile	III,IV	0.118	0.734	.014	18	view →
KIRP	OS	Tertile	All	0.211	0.697	.015	15	view →
SARC	DFS	Tertile	All	0.151	0.594	.018	9	view →
LGG	DFS	Tertile	All	0.544	0.845	.022	6	view →
DLBC	OS	Tertile	All	0.754	0.964	.045	3	view →

Pink = unfavorable, green = favorable. Showing the 7 strongest of 7 lineages.

IGLVI-68–BLCA (DFS)

Open the BLCA breakdown →